CA2014925A1 - Derives macrolides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents

Derives macrolides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Info

Publication number
CA2014925A1
CA2014925A1 CA002014925A CA2014925A CA2014925A1 CA 2014925 A1 CA2014925 A1 CA 2014925A1 CA 002014925 A CA002014925 A CA 002014925A CA 2014925 A CA2014925 A CA 2014925A CA 2014925 A1 CA2014925 A1 CA 2014925A1
Authority
CA
Canada
Prior art keywords
formula
group
derivative
hydrogen atom
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002014925A
Other languages
English (en)
French (fr)
Inventor
Gabor Lukacs
Catherine Duchatelle-Ruggeri
Alain Olesker
Li Ming
Sylvie Bobillot
Ton Thatthang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Servier de Medecine Translationnelle SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of CA2014925A1 publication Critical patent/CA2014925A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002014925A 1989-04-20 1990-04-19 Derives macrolides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent Abandoned CA2014925A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR89.05246 1989-04-20
FR8905246A FR2646081A1 (enExample) 1989-04-20 1989-04-20

Publications (1)

Publication Number Publication Date
CA2014925A1 true CA2014925A1 (fr) 1990-10-20

Family

ID=9380938

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002014925A Abandoned CA2014925A1 (fr) 1989-04-20 1990-04-19 Derives macrolides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Country Status (10)

Country Link
US (1) US5043324A (enExample)
EP (1) EP0394135A1 (enExample)
JP (1) JPH02292296A (enExample)
AU (1) AU625201B2 (enExample)
CA (1) CA2014925A1 (enExample)
FR (1) FR2646081A1 (enExample)
NZ (1) NZ233378A (enExample)
OA (1) OA09447A (enExample)
PT (1) PT93807A (enExample)
ZA (1) ZA903008B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2067520A1 (en) * 1991-05-02 1992-11-03 Tats Matsuoka Treatment of mastitis
US5677287A (en) * 1993-03-18 1997-10-14 Pfizer Inc. Antibacterial 16-membered ring macrolides containing olefins at C-20
AU6980094A (en) * 1993-07-15 1995-02-13 Pfizer Inc. Amide derivatives of 16-membered ring antibiotic macrolides
EP0778283A3 (en) * 1995-12-05 1998-01-28 Pfizer Inc. Antibiotic macrolides
US6753415B2 (en) * 2002-04-19 2004-06-22 Enanta Pharmaceuticals, Inc. 23-O-substituted 5-O-mycaminosyltylonide derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8004922A (nl) * 1979-09-19 1981-03-23 Toyo Jozo Kk Deformyltylosinederivaten.
DE2939154C2 (de) 1979-09-27 1982-08-05 Neumünstersche Maschinen- und Apparatebau GmbH (Neumag), 2350 Neumünster Stapelfaserschneidmaschine
IL71032A0 (en) * 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives
US4468511A (en) * 1983-02-28 1984-08-28 Eli Lilly And Company C-20- And C-23-Modified macrolide derivatives
JPS62113036U (enExample) * 1985-12-30 1987-07-18
JPH01147945U (enExample) * 1988-04-01 1989-10-13

Also Published As

Publication number Publication date
AU625201B2 (en) 1992-07-02
JPH02292296A (ja) 1990-12-03
FR2646081A1 (enExample) 1990-10-26
PT93807A (pt) 1990-11-20
AU5362890A (en) 1990-10-25
US5043324A (en) 1991-08-27
ZA903008B (en) 1991-01-30
EP0394135A1 (fr) 1990-10-24
OA09447A (fr) 1992-10-15
NZ233378A (en) 1991-10-25

Similar Documents

Publication Publication Date Title
CA2055912C (fr) Nouveaux derives de l'erythromycine, leur procede de preparation, les nouveaux intermediaires obtenus et leur application comme medicaments
EP0596802B1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation, leur application comme médicaments
KR0166096B1 (ko) 6-0-메틸에리쓰로마이신 a 유도체
JP3083102B2 (ja) エリスロマイシンおよびアジスロマイシンの３”−デスメトキシ誘導体
JPH09511235A (ja) ９−デオキソタキサン化合物
FR2473525A1 (fr) Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2629715A1 (fr) Derives de l'adenosine, leur procede de preparation et leur utilisation en therapeutique
EP0885234A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
WO1999035155A1 (fr) Nouveaux amides aromatiques, leur procede de preparation et leur application comme medicaments
JPH04504259A (ja) エリスロマイシン誘導体
BE897843A (fr) Derives biologiquement actifs de 2, 5-piperazinediones, procede pour leur preparation et compositions pharmaceutique en contenant
CA2258152C (fr) Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
FR2483929A1 (fr) Nouvelles adenosines n6-substituees utiles comme medicaments antihypertenseurs, compositions therapeutiques et formes pharmaceutiques les contenant, et leur procede de preparation
EP0394135A1 (fr) Noveaux dérivés macrolides, leur procédé de préparation et leur compositions pharmaceutiques qui les contiennent
EP0292352A2 (fr) Nouveaux dérivés macrolides, leur procédé de préparation et les compositions pharmaceutiques les contenant
FR2754821A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
OA10557A (fr) Nouveaux dérivés de la tylosine leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0772630B1 (fr) Derives de streptogramine, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0656364B1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments
JPWO2004067544A1 (ja) 新規化合物カプラゼンとカプラゼン誘導体、ならびに新規化合物カプラゾールとカプラゾール誘導体
FR2534588A2 (fr) Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2614894A1 (fr) Nouvelles oximes derivees de la tylosine, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2626576A1 (fr) Nouveaux derives de la carbomycine b, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN121471116A (zh) 含有磺酰基的化合物及其制备和应用
JPH0278695A (ja) エリスロマイシン誘導体

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 19941019